Home/Lifordi Immunotherapeutics/Arthur Tzianabos, Ph.D.
AT

Arthur Tzianabos, Ph.D.

President & Chief Executive Officer

Lifordi Immunotherapeutics

Lifordi Immunotherapeutics Pipeline

DrugIndicationPhase
LFD-200Rheumatoid ArthritisPhase 1